News

Raw Materials vs. Crushing Commercial Tablets

Thursday, July 5, 2018

Knowing when it is suitable for crushing commercial products for a suspension is crucial for ensuring the formulation remains uniform and stable.

Versatile - Advancing Outcomes for Patients with Chronic Pain

Thursday, April 12, 2018

Versatile™ is the only cream base proven to provide simultaneous percutaneous absorption of six commonly prescribed pain drugs while remaining durable and elegant.

Fagron Online CPD Activity on AJP Advancing Your Practice Series

Wednesday, March 28, 2018

Increase your compounding knowledge while earning CPD points on our course at the AJP.

SyrSpend® SF PH4 Stability

Friday, June 9, 2017

New research reveals the benefits of SyrSpend® SF PH4 stability with active ingredients of various pharmaceutical classes

NEW: SyrSpend® SF content uniformity publication

Tuesday, April 4, 2017

A new published article in the International Journal of Pharmaceutical Compounding discusses suspensions as a valuable alternative for compounded capsules with respect to content uniformity.

Parabens in oral pharmaceutical preparations

Thursday, January 12, 2017

The use of parabens is associated with certain health-risks in humans and should be avoided whenever possible as stated in guidelines by the European Medicines Agency (EMA).

Happy holidays from Fagron Australia!

Friday, December 16, 2016

The team at Fagron Compounding Supplies Australia wishes you happy holidays and a wonderful 2017!

New SyrSpend® SF Alka publication

Friday, December 9, 2016

A new peer-reviewed study, published in the European Journal of Hospital Pharmacy, demonstrated the compatibility of several proton pump inhibitors (PPIs) in SyrSpend® SF Alka. SyrSpend® SF Alka.

FDA and MHLW ban triclosan from OTC antibacterial hand and body washes

Monday, November 14, 2016

The US FDA issued the final rule in September, establishing that over-the-counter (OTC) consumer antiseptic wash products can no longer contain certain ingredients, including triclosan.

The EC bans methylisothiazolinone (MI) in leave-on products

Friday, September 9, 2016

Following the public consultation on the use of methylisothiazolinone (MI), the European Commission (EC) now announced the ban for the use of MI in leave-on products as of 12 February 2017.

Pentravan® and Pentravan® Plus

Thursday, September 8, 2016

Pentravan® and Pentravan® Plus are oil-in-water emulsion bases that uses liposomal technology for effective transdermal drug delivery.

Oseltamivir phosphate in SyrSpend® SF PH4

Thursday, July 14, 2016

Although the influenza activity remains at low levels in Australia, an increase in activity has recently been observed in some areas. Outbreaks of influenza can create a higher demand for oseltamivir, particularly in the oral liquid dose form.

SyrSpend® SF in clinical trials

Friday, July 1, 2016

Fagron is happy to announce that SyrSpend® SF is currently being recognized by large pharmaceutical companies for its quality and compatibility, as is demonstrated by the fact that two big pharmaceutical companies are using the product for their clinical

Compounding mupirocin ointment during shortage

Monday, May 30, 2016

Fagron carries all ingredients to compound mupirocin 2% ointment and cream. Our Occluvan™ anhydrous ointment base is an ideal vehicle to prepare the mupirocin ointment, as it's easily spreadable and has a skin-friendly formulation.

SyrSpend® SF – Scientific evidence for another 10 APIs

Thursday, April 14, 2016

In a study published in the April edition of Die Pharmazie, the physical and chemical stability of 10 APIs was studied in SyrSpend® SF PH4 liquid

New SyrSpend® SF Publication

Tuesday, March 22, 2016

With SyrSpend® SF, Fagron is creating the world's largest compatibility library for a single oral liquid vehicle. A new article has recently been published in the International Journal of Pharmaceutical Compounding (IJPC).

Spotlight on excipients in paediatric dosage forms

Monday, March 7, 2016

Medication for children is frequently not commercially available.The majority of children can't swallow tablets or capsules until the age of six. In many cases, an oral liquid dosage form is a suitable alternative. However, when reviewing some formulation

Powder containment hood

Monday, February 15, 2016

Serious health risks are associated with exposure to hormones and other powders involved in pharmaceutical compounding. Here at Fagron we carry three sizes of powder containment hoods to minimise your staff's exposure to harmful chemicals.

Purchase compounding equipment in February and get free InStore training

Tuesday, February 2, 2016

For the entire month we will be highlighting our range of high-quality compounding equipment. With the new year in full swing, it's a good time to assure yourself that your compounding lab has the best equipment suited to your unique setting, providing...

Happy Holidays!

Monday, December 21, 2015

The team at Fagron Compounding Supplies Australia wishes you happy holidays and a wonderful 2016! Fagron will remain open on all business days except for public holidays.

Expanding SyrSpend® SF’s scientific stability database

Friday, November 27, 2015

A new article has recently been published in the high-impact Journal of Pharmaceutical and Biomedical Analysis. This article discusses the stability of the following 10 drugs, from a variety of pharmacological classes, in SyrSpend® SF.

What is Progesterone Wettable?

Wednesday, November 4, 2015

Progesterone is available in two forms, Progesterone Micronised and Progesterone Wettable.

Creating the world’s largest compatibility library for a single oral liquid vehicle

Tuesday, October 27, 2015

Fagron has started to study the stability of more than 100 commonly used active pharmaceutical ingredients (APIs) in SyrSpend® SF. The first results of these studies were published this month in the International Journal of Pharmaceutical Compounding.

Easily compound a pleasant-tasting omeprazole suspension

Wednesday, October 7, 2015

Fagron has your solution for compounding omeprazole suspensions.

World Pharmacists Day - 25 September 2015

Tuesday, September 15, 2015

This September we are celebrating World Pharmacists Day (25/9).

SyrSpend® SF compatibility data: new studies!

Monday, July 27, 2015

SyrSpend® SF, Fagron's gluten-, sugar-, alcohol-free suspending vehicle with Active Suspending Technology, is the preferred suspending vehicle for many pharmacists, because of the ingredient safety and excellent compatibility with active ingredients.

New evidence on swallowing difficulties

Tuesday, July 21, 2015

According to a recent study* performed in five community pharmacies in Brisbane, 16.5% of the population experiences swallowing difficulties, often without informing their pharmacist or GP.

Over 40 different nutritionals in stock now!

Thursday, May 21, 2015

In response to many requests, Fagron offers over 40 different nutritionals, ranging from Arginine to Zinc Picolinate.

Fagron Advanced Derma, free of harmful and controversial ingredients

Friday, April 17, 2015

Excipients are essential ingredients of almost any dermatological product and required to assure numerous properties of the final preparation, such as spreadability, solubility and stability. Perspectives about the safety and tolerance of ingredients in d

New SyrSpend® SF formulations in Compounding Matters!

Wednesday, April 1, 2015

Almost 200 new compounding instructions for more than 120 different active pharmaceutical ingredients (APIs) have been added to Compounding Matters. Compounding Matters is Fagron’s free and easy accessible formulations database.

NEW! Vitamin D3 100,000 IU/g

Tuesday, March 24, 2015

Fagron now introduces Vitamin D3 100,000 IU/g to accomodate high-dose vitamin D3 supplementation.

Watch on Demand: Fagron Academy Webinar "Innovations in Compounding"

Thursday, February 26, 2015

Fagron Australia hosted its second successful webinar on 25 February. Do you want to watch it again or did you miss it?

Fagron Academy presents: 'Innovations in Compounding' webinar

Friday, February 6, 2015

Following a succesful first webinar on oral suspensions, Fagron Academy Australia proudly announces its second webinar. On February 25, 2015 Fagron professionals will be discussing the latest innovations in pharmaceutical compounding.

NEW: Clinical study with combination pain therapy in Versatile™

Wednesday, December 10, 2014

A recent randomised, double-blind, placebo controlled study compared treatment with a combination of multiple APIs in Versatile™ to Versatile™ alone in patients with peripheral neuropathy.

NEW! Fagron Advanced Derma - your total derma solution

Wednesday, November 19, 2014

Fagron Australia proudly launches Fagron Advanced Derma! The product line is a total solution for dermatological and cosmeceutical compounding with excellent stability and optimal ingredient safety.

In need of compounding equipment?

Wednesday, November 12, 2014

Fagron not only sells top-of-the-line bases, vehicles, and chemicals but also the highest quality equipment and supplies. Fagron carries everything from

Fagron Academy presents: 'How to Easily Compound Oral Suspensions' webinar

Tuesday, November 4, 2014

Fagron Australia is proud to invite you to Australia's very first Fagron Academy event. Fagron professionals will be hosting a free webinar to inform you about the latest developments in compounding oral suspensions.

Rest assured with Fagron's superior global quality system

Thursday, October 30, 2014

More than 200,000 customers worldwide have access to over 5,000 high-quality pharmaceutical raw materials, vehicles and Fagron trademark products, thanks to Fagron’s superior global quality system.

Compounding Matters formulation database

Thursday, October 16, 2014

Do you have access to Fagron Compounding Matters database? This formulation database contains an extensive list of compounding formulations

25 September: World Pharmacists Day

Thursday, September 25, 2014

On 25 September the world pays attention to the role of the pharmacist in improving health in every corner of the world. This years’ theme is:

Pentravan® performance: additional scientific evidence

Tuesday, August 19, 2014

There is an increasing interest for Pentravan® transdermal cream in scientific literature(1-4). A new publication in the most recent edition of the International Journal of Pharmaceutical Compounding concludes that human female sexual hormones

SyrSpend® SF: the new global standard in oral liquid therapy

Thursday, July 10, 2014

With the global launch of SyrSpend® SF Fagron introduces an unparalleled vehicle range for compounding oral liquid medication, based on the latest scientific insights.

Fagron Concepts

News archive

Pharmacists

Hospitals

What is compounding?

Overview

FACTS Technical Support

GMP Quality

Quality Management

Quality Activities

Supplier Qualifications and Audits

Fagron Concepts

News

News archive